These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34863976)

  • 1. Epoxylipids and soluble epoxide hydrolase in heart diseases.
    Imig JD; Cervenka L; Neckar J
    Biochem Pharmacol; 2022 Jan; 195():114866. PubMed ID: 34863976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble epoxide hydrolase inhibitors and heart failure.
    Qiu H; Li N; Liu JY; Harris TR; Hammock BD; Chiamvimonvat N
    Cardiovasc Ther; 2011 Apr; 29(2):99-111. PubMed ID: 20433684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
    Roche C; Besnier M; Cassel R; Harouki N; Coquerel D; Guerrot D; Nicol L; Loizon E; Remy-Jouet I; Morisseau C; Mulder P; Ouvrard-Pascaud A; Madec AM; Richard V; Bellien J
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1020-9. PubMed ID: 25724490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches.
    Li N; Liu JY; Timofeyev V; Qiu H; Hwang SH; Tuteja D; Lu L; Yang J; Mochida H; Low R; Hammock BD; Chiamvimonvat N
    J Mol Cell Cardiol; 2009 Dec; 47(6):835-45. PubMed ID: 19716829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors.
    Inceoglu B; Bettaieb A; Haj FG; Gomes AV; Hammock BD
    Prostaglandins Other Lipid Mediat; 2017 Nov; 133():68-78. PubMed ID: 28847566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
    Islam O; Patil P; Goswami SK; Razdan R; Inamdar MN; Rizwan M; Mathew J; Inceoglu B; Stephen Lee KS; Hwang SH; Hammock BD
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28296232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure.
    Merabet N; Bellien J; Glevarec E; Nicol L; Lucas D; Remy-Jouet I; Bounoure F; Dreano Y; Wecker D; Thuillez C; Mulder P
    J Mol Cell Cardiol; 2012 Mar; 52(3):660-6. PubMed ID: 22155238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
    Červenka L; Melenovský V; Husková Z; Škaroupková P; Nishiyama A; Sadowski J
    Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):795-807. PubMed ID: 25969338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoxides and soluble epoxide hydrolase in cardiovascular physiology.
    Imig JD
    Physiol Rev; 2012 Jan; 92(1):101-30. PubMed ID: 22298653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of soluble epoxide hydrolase (sEH) activity.
    Morisseau C; Hammock BD
    Curr Protoc Toxicol; 2007; Chapter 4():Unit 4.23. PubMed ID: 23045145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative Importance of Soluble and Microsomal Epoxide Hydrolases for the Hydrolysis of Epoxy-Fatty Acids in Human Tissues.
    Morisseau C; Kodani SD; Kamita SG; Yang J; Lee KSS; Hammock BD
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and characterization of an epoxide hydrolase from Anopheles gambiae with high activity on epoxy fatty acids.
    Xu J; Morisseau C; Hammock BD
    Insect Biochem Mol Biol; 2014 Nov; 54():42-52. PubMed ID: 25173592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble epoxide hydrolase activation by S-nitrosation contributes to cardiac ischemia-reperfusion injury.
    Ding Y; Li Y; Zhang X; He J; Lu D; Fang X; Wang Y; Wang J; Zhang Y; Qiao X; Gan LM; Chen C; Zhu Y
    J Mol Cell Cardiol; 2017 Sep; 110():70-79. PubMed ID: 28736260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic deletion of soluble epoxide hydrolase provides cardioprotective responses following myocardial infarction in aged mice.
    Jamieson KL; Samokhvalov V; Akhnokh MK; Lee K; Cho WJ; Takawale A; Wang X; Kassiri Z; Seubert JM
    Prostaglandins Other Lipid Mediat; 2017 Sep; 132():47-58. PubMed ID: 28104457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble epoxide hydrolase: a new target for cardioprotection.
    Gross GJ; Nithipatikom K
    Curr Opin Investig Drugs; 2009 Mar; 10(3):253-8. PubMed ID: 19333883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases.
    Wagner KM; McReynolds CB; Schmidt WK; Hammock BD
    Pharmacol Ther; 2017 Dec; 180():62-76. PubMed ID: 28642117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
    Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
    Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Epoxide Hydrolase in Aged Female Mice and Human Explanted Hearts Following Ischemic Injury.
    Jamieson KL; Darwesh AM; Sosnowski DK; Zhang H; Shah S; Zhabyeyev P; Yang J; Hammock BD; Edin ML; Zeldin DC; Oudit GY; Kassiri Z; Seubert JM
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
    Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble epoxide hydrolase inhibition exerts beneficial anti-remodeling actions post-myocardial infarction.
    Kompa AR; Wang BH; Xu G; Zhang Y; Ho PY; Eisennagel S; Thalji RK; Marino JP; Kelly DJ; Behm DJ; Krum H
    Int J Cardiol; 2013 Jul; 167(1):210-9. PubMed ID: 22236509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.